Agios Pharmaceuticals
(AGIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -411,472 | -346,028 | -314,670 | -198,471 | -117,732 |
| Depreciation Amortization | 4,893 | 3,335 | 6,421 | 6,481 | 3,881 |
| Income taxes - deferred | N/A | N/A | N/A | 1,346 | N/A |
| Accounts receivable | N/A | -5,090 | 2,438 | 3,339 | -1,733 |
| Accounts payable and accrued liabilities | 4,162 | -5,488 | 5,329 | 3,501 | 4,215 |
| Other Working Capital | -7,275 | -35,105 | -24,832 | 187,120 | 4,906 |
| Other Operating Activity | 39,070 | 83,955 | 40,082 | 35,246 | 29,514 |
| Operating Cash Flow | $-370,622 | $-304,421 | $-285,232 | $38,562 | $-76,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,028 | -6,986 | -4,627 | -9,915 | -20,164 |
| Purchase Of Investment | -488,566 | -933,320 | -688,702 | -506,067 | -353,177 |
| Sale Of Investment | 592,177 | 666,481 | 635,421 | 396,632 | 501,650 |
| Other Investing Activity | -143 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $91,440 | $-273,825 | $-57,908 | $-119,350 | $128,309 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -113 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 289,724 | 546,415 | 284,472 | 170,008 | 6,580 |
| Other Financing Activity | 0 | -391 | 638 | -230 | -207 |
| Financing Cash Flow | $289,611 | $546,024 | $285,110 | $169,778 | $6,373 |
| Beginning Cash Position | 70,502 | 102,724 | 160,754 | 71,764 | 14,031 |
| End Cash Position | 80,931 | 70,502 | 102,724 | 160,754 | 71,764 |
| Net Cash Flow | $10,429 | $-32,222 | $-58,030 | $88,990 | $57,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | -370,622 | -304,421 | -285,232 | 38,562 | -76,949 |
| Capital Expenditure | -12,028 | -6,986 | -4,627 | -9,915 | -20,164 |
| Free Cash Flow | -382,650 | -311,407 | -289,859 | 28,647 | -97,113 |